Logo image of MARR.MI

MARR SPA (MARR.MI) Stock Fundamental Analysis

Europe - BIT:MARR - IT0003428445 - Common Stock

9.34 EUR
+0.05 (+0.54%)
Last: 9/18/2025, 1:42:21 PM
Fundamental Rating

4

MARR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 22 industry peers in the Consumer Staples Distribution & Retail industry. MARR has only an average score on both its financial health and profitability. MARR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MARR had positive earnings in the past year.
In the past year MARR had a positive cash flow from operations.
MARR had positive earnings in 4 of the past 5 years.
MARR had a positive operating cash flow in 4 of the past 5 years.
MARR.MI Yearly Net Income VS EBIT VS OCF VS FCFMARR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.98%, MARR is in line with its industry, outperforming 59.09% of the companies in the same industry.
MARR has a better Return On Equity (17.04%) than 72.73% of its industry peers.
The Return On Invested Capital of MARR (9.46%) is better than 72.73% of its industry peers.
MARR had an Average Return On Invested Capital over the past 3 years of 6.59%. This is below the industry average of 9.17%.
The 3 year average ROIC (6.59%) for MARR is below the current ROIC(9.46%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.98%
ROE 17.04%
ROIC 9.46%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
MARR.MI Yearly ROA, ROE, ROICMARR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

MARR has a Profit Margin (1.76%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of MARR has declined.
MARR has a Operating Margin (3.09%) which is comparable to the rest of the industry.
MARR's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 7.74%, MARR is doing worse than 86.36% of the companies in the same industry.
In the last couple of years the Gross Margin of MARR has grown nicely.
Industry RankSector Rank
OM 3.09%
PM (TTM) 1.76%
GM 7.74%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
MARR.MI Yearly Profit, Operating, Gross MarginsMARR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MARR is still creating some value.
Compared to 1 year ago, MARR has less shares outstanding
The number of shares outstanding for MARR has been reduced compared to 5 years ago.
MARR has about the same debt/assets ratio as last year.
MARR.MI Yearly Shares OutstandingMARR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MARR.MI Yearly Total Debt VS Total AssetsMARR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

MARR has an Altman-Z score of 3.36. This indicates that MARR is financially healthy and has little risk of bankruptcy at the moment.
MARR's Altman-Z score of 3.36 is fine compared to the rest of the industry. MARR outperforms 68.18% of its industry peers.
The Debt to FCF ratio of MARR is 27.61, which is on the high side as it means it would take MARR, 27.61 years of fcf income to pay off all of its debts.
MARR has a Debt to FCF ratio of 27.61. This is in the lower half of the industry: MARR underperforms 77.27% of its industry peers.
A Debt/Equity ratio of 1.14 is on the high side and indicates that MARR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.14, MARR is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.61
Altman-Z 3.36
ROIC/WACC1.52
WACC6.23%
MARR.MI Yearly LT Debt VS Equity VS FCFMARR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

MARR has a Current Ratio of 1.44. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.44, MARR belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
A Quick Ratio of 1.02 indicates that MARR should not have too much problems paying its short term obligations.
MARR has a better Quick ratio (1.02) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.02
MARR.MI Yearly Current Assets VS Current LiabilitesMARR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for MARR have decreased strongly by -21.35% in the last year.
The Earnings Per Share has been decreasing by -8.05% on average over the past years.
MARR shows a small growth in Revenue. In the last year, the Revenue has grown by 0.56%.
MARR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.24% yearly.
EPS 1Y (TTM)-21.35%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-27.17%
Revenue 1Y (TTM)0.56%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%0.97%

3.2 Future

MARR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.48% yearly.
MARR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.62% yearly.
EPS Next Y5.6%
EPS Next 2Y9.61%
EPS Next 3Y10.48%
EPS Next 5YN/A
Revenue Next Year2.54%
Revenue Next 2Y2.87%
Revenue Next 3Y3.32%
Revenue Next 5Y3.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MARR.MI Yearly Revenue VS EstimatesMARR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
MARR.MI Yearly EPS VS EstimatesMARR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.25, which indicates a very decent valuation of MARR.
Based on the Price/Earnings ratio, MARR is valued a bit cheaper than 77.27% of the companies in the same industry.
When comparing the Price/Earnings ratio of MARR to the average of the S&P500 Index (27.20), we can say MARR is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.91, the valuation of MARR can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MARR is on the same level as its industry peers.
MARR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.25
Fwd PE 11.91
MARR.MI Price Earnings VS Forward Price EarningsMARR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

MARR's Enterprise Value to EBITDA ratio is in line with the industry average.
MARR's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. MARR is more expensive than 68.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 33.21
EV/EBITDA 7.81
MARR.MI Per share dataMARR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MARR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.01
PEG (5Y)N/A
EPS Next 2Y9.61%
EPS Next 3Y10.48%

6

5. Dividend

5.1 Amount

MARR has a Yearly Dividend Yield of 6.59%, which is a nice return.
Compared to an average industry Dividend Yield of 4.06, MARR pays a better dividend. On top of this MARR pays more dividend than 90.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, MARR pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.59%

5.2 History

The dividend of MARR decreases each year by -5.06%.
Dividend Growth(5Y)-5.06%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MARR pays out 71.68% of its income as dividend. This is not a sustainable payout ratio.
DP71.68%
EPS Next 2Y9.61%
EPS Next 3Y10.48%
MARR.MI Yearly Income VS Free CF VS DividendMARR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M
MARR.MI Dividend Payout.MARR.MI Dividend Payout, showing the Payout Ratio.MARR.MI Dividend Payout.PayoutRetained Earnings

MARR SPA

BIT:MARR (9/18/2025, 1:42:21 PM)

9.34

+0.05 (+0.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)08-04 2025-08-04
Earnings (Next)11-14 2025-11-14
Inst Owners23.6%
Inst Owner ChangeN/A
Ins Owners50.42%
Ins Owner ChangeN/A
Market Cap621.39M
Analysts80
Price Target12.6 (34.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.59%
Yearly Dividend0.6
Dividend Growth(5Y)-5.06%
DP71.68%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.27%
PT rev (3m)0.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.74%
EPS NY rev (3m)-5.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)-0.5%
Valuation
Industry RankSector Rank
PE 11.25
Fwd PE 11.91
P/S 0.2
P/FCF 33.21
P/OCF 11.6
P/B 1.97
P/tB 4.26
EV/EBITDA 7.81
EPS(TTM)0.83
EY8.89%
EPS(NY)0.78
Fwd EY8.39%
FCF(TTM)0.28
FCFY3.01%
OCF(TTM)0.8
OCFY8.62%
SpS45.79
BVpS4.74
TBVpS2.19
PEG (NY)2.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.98%
ROE 17.04%
ROCE 13.54%
ROIC 9.46%
ROICexc 13.6%
ROICexgc 20.95%
OM 3.09%
PM (TTM) 1.76%
GM 7.74%
FCFM 0.61%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
ROICexc(3y)9.5%
ROICexc(5y)7.64%
ROICexgc(3y)14.76%
ROICexgc(5y)12.13%
ROCE(3y)9.43%
ROCE(5y)7.37%
ROICexcg growth 3Y-2.5%
ROICexcg growth 5Y-13.81%
ROICexc growth 3Y0.65%
ROICexc growth 5Y-11.99%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
F-Score3
Asset Turnover2.26
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 27.61
Debt/EBITDA 3.03
Cap/Depr 144.76%
Cap/Sales 1.14%
Interest Coverage 250
Cash Conversion 45.32%
Profit Quality 34.81%
Current Ratio 1.44
Quick Ratio 1.02
Altman-Z 3.36
F-Score3
WACC6.23%
ROIC/WACC1.52
Cap/Depr(3y)107.37%
Cap/Depr(5y)94.25%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.35%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-27.17%
EPS Next Y5.6%
EPS Next 2Y9.61%
EPS Next 3Y10.48%
EPS Next 5YN/A
Revenue 1Y (TTM)0.56%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%0.97%
Revenue Next Year2.54%
Revenue Next 2Y2.87%
Revenue Next 3Y3.32%
Revenue Next 5Y3.62%
EBIT growth 1Y-23.54%
EBIT growth 3Y7.4%
EBIT growth 5Y-6.98%
EBIT Next Year52.54%
EBIT Next 3Y22.77%
EBIT Next 5YN/A
FCF growth 1Y27.25%
FCF growth 3Y-31.25%
FCF growth 5Y-12.02%
OCF growth 1Y41.34%
OCF growth 3Y-19.18%
OCF growth 5Y-3.88%